22 May 2013
Keywords: pulls, plug, eltanolone, pharmacia, upjohn, decided, discontinue
Article | 19 February 1996
Pharmacia & Upjohn has decided to discontinue development of its
intravenous anesthetic eltanolone after a review of data from Phase III
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 February 1996
21 May 2013
© 2013 thepharmaletter.com